Suchergebnisse
Axsome's Q2 Earnings Meet Estimates, Auvelity Drives Y/Y Revenues
Axsome Therapeutics AXSM incurred a loss of 99 cents per share in the second quarter of 2026, which was in line with the Zacks Consensus Estimate. The company had reported a loss of 97 cents per
Almonty Industries Inc. (ALM) Q2 Earnings Match Estimates
Almonty Industries Inc. (ALM) came out with quarterly earnings of $0.1 per share, in line with the Zacks Consensus Estimate . This compares to a loss of $0.05 per share a year ago. These figures are